Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00141258
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date October 2005
Completion date August 2006

See also
  Status Clinical Trial Phase
Completed NCT01954121 - Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures Phase 3
Completed NCT01630057 - Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug Phase 4
Completed NCT00327717 - Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures Phase 3
Completed NCT00537238 - Pregabalin Versus Levetiracetam In Partial Seizures Phase 3
Completed NCT03340064 - A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age Phase 3
Terminated NCT00407797 - Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial Phase 4
Completed NCT01136954 - A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) Phase 3
Completed NCT04257604 - A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
Completed NCT01392768 - Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization Phase 3
Completed NCT01063764 - An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Phase 3
Completed NCT00102713 - A Study for Treatment of Partial Seizures in Children Phase 3
Completed NCT01262677 - Once-A-Day Pregabalin For Partial Seizures Phase 3